Ritmocor (2,3,4,5,6-pentahydroxycaproic acid magnesium salt) capsules №48

Description

Ritmocor (2,3,4,5,6-pentahydroxycaproic acid magnesium salt) capsules №48

Composition

active ingredients: 1 capsule contains 2,3,4,5,6-pentahydroxycaproic acid magnesium salt in 100% substance 300 mg,

60 mg of 2,3,4,5,6-pentahydroxycaproic acid potassium salt in terms of 100% substance;

excipients: colloidal anhydrous silicon dioxide, calcium stearate.

Medicinal form

Capsules.

The main physical and chemical properties: hard gelatin capsules of cylindrical shape with hemispherical ends of white-green color (with the inscription “FarKoS” or without an inscription). The contents of the capsule are a white or almost white odorless powder.

Pharmacotherapeutic group

Mineral supplements. Magnesium preparations.
ATX code A12S S.

Pharmacological properties

This is a magnesium preparation. Magnesium affects almost all bodily functions. It is one of the main elements in energy processes, it is necessary for the formation of bones and teeth, regulates the permeability of cell membranes and their organelles, participates in the functioning of more than 300 enzymes, protects cells from excessive calcium intake, is a calcium antagonist, increases the activity of the antioxidant defense system, reduces convulsive readiness of the body (with eclampsia, preeclampsia), has antithrombotic activity. With magnesium deficiency, neurological disorders (decreased concentration, tremors, muscle spasms) can be observed.

Indications

Ritmocor capsules is used:

• for the treatment / prevention of magnesium deficiency, which can manifest itself as increased excitability, irritability, anxiety, transient weakness, sleep disturbances, anxiety, muscle cramps, tingling sensations in the muscles.
• for complex treatment, prevention of ischemic heart disease (myocardial infarction, angina pectoris), angiospasm;
• for complex treatment, prevention of dyslipidemia (lipid metabolism disorders), atherosclerosis;
• for complex treatment, prevention of arteriolitis, arteritis.

Contraindications

Ritmocor capsules is not used:

• with intolerance to the components of the drug;
• with the simultaneous use of other medicines containing magnesium;
• with severe bradycardia;
• with myasthenia gravis;
• with urolithiasis associated with metabolic disorders of calcium, magnesium, ammonium phosphate;
• with atrioventricular block;
• with serious impairment of kidney function;
• with hypermagnesemia (increased concentration of magnesium in the blood);
• with cardiogenic shock (with systolic blood pressure in adults below 90 mm Hg);
• in a coma of unexplained etiology;
• with decompensated form of diabetes mellitus;
• with Addison’s disease;
• with hyperkalemia (increased concentration of potassium in the blood).

Application during pregnancy and lactation

The drug Ritmocor capsules is used during these periods as prescribed by a doctor.

Method of administration and dosage

Ritmocor capsules is administered orally 10 minutes before meals.
The standard therapeutic dose for adults is 1-2 capsules 3-4 times a day, the prophylactic dose is 1 capsule 3 times a day.
The duration of treatment is determined individually.

Overdose

Symptoms: neurological disorders, vomiting, impaired atrioventricular and ventricular conduction, respiratory failure, decreased blood pressure. If signs of overdose are detected, the use of the drug should be discontinued, seek medical help.
In case of an overdose, the introduction of a 10% solution of calcium chloride for 5-10 minutes, forced diuresis (the introduction of a large volume of fluid into the body and the simultaneous administration of diuretics), dialysis are shown.

Side effects

Possible manifestations of hypersensitivity (including anaphylaxis, allergic dermatitis, rash, itching, urticaria, Quincke’s edema), digestive disorders.